Keep reading — and keep visiting — for ongoing insights from our Innovation Studio, our world-renowned founders, and the dynamic aesthetics and dermatology market. We’ll bring you the latest updates on our therapeutic breakthroughs, takeaways from key industry events, and opportunities to engage with the Blossom Innovations team.
Blossom Innovations founder and CEO Dr. Irina Erenburg recently discussed this critical question with fellow executives and leading capital managers at the 2019 Aesthetics Innovation Summit. Here’s what they see investors looking for in new aesthetics companies.
Nail fungus, or onychomycosis, is a familiar problem that’s often seen as little more than an unsightly and hard to treat cosmetic issue. But for many of the millions of people worldwide who are affected by this under-treated condition, the impact may be far greater — and far more serious.
Blossom is headed to the 2020 Dermatology Innovation Forum.
Blossom Innovations wins innovation award at 2020 IMCAS World Congress.
The global market for dermal fillers is growing faster than ever. But as demand continues to increase, so are the serious risks of mis-targeted injections.
